{"id":8649,"date":"2026-06-02T11:22:10","date_gmt":"2026-06-02T09:22:10","guid":{"rendered":"https:\/\/bioceltix.com\/?p=8649"},"modified":"2026-06-02T11:22:10","modified_gmt":"2026-06-02T09:22:10","slug":"ordinary-general-meeting-convened-for-23-june-2026","status":"publish","type":"post","link":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/","title":{"rendered":"Ordinary General Meeting convened for 23 June 2026"},"content":{"rendered":"<p>_MACHINE TRANSLATION_<\/p>\n<p>The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cIssuer\u201d, the \u201cCompany\u201d), announces that the Ordinary General Meeting of the Issuer has been convened for 23 June 2026, to commence at 12:00 p.m. at the registered office of the Management Board of the Company, i.e. in Wroc\u0142aw (51-317), at 57-59 Bierutowska Street, Building III (Wroc\u0142aw Business Parks area).<\/p>\n<p>The detailed agenda of the convened Ordinary General Meeting of the Company includes:<\/p>\n<ol>\n<li>Opening of the General Meeting.<\/li>\n<li>Election of the Chairperson of the General Meeting.<\/li>\n<li>Confirmation of the correctness of convening the General Meeting and its capacity to adopt resolutions.<\/li>\n<li>Adoption of the agenda.<\/li>\n<li>Consideration of the Management Board\u2019s report on the activities of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Consideration of the financial statements of BIOCELTIX S.A. for the financial year 2025, including the report of the independent statutory auditor on the audit of the financial statements.<\/li>\n<li>Consideration of the Management Board\u2019s motion regarding the coverage of the loss of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Consideration of the Supervisory Board\u2019s report on the activities of BIOCELTIX S.A. for the financial year 2025 and the results of the Supervisory Board\u2019s assessment of the financial statements and the Management Board\u2019s report on activities for the financial year 2025.<\/li>\n<li>Adoption of a resolution on the approval of the Supervisory Board\u2019s report on the activities of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Adoption of a resolution on the approval of the Management Board\u2019s report on the activities of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Adoption of a resolution on the approval of the financial statements of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Adoption of a resolution on the coverage of the loss of BIOCELTIX S.A. for the financial year 2025.<\/li>\n<li>Adoption of resolutions on granting discharge to the members of the Management Board of BIOCELTIX S.A. for the performance of their duties in 2025.<\/li>\n<li>Adoption of resolutions on granting discharge to the members of the Supervisory Board of BIOCELTIX S.A. for the performance of their duties in 2025.<\/li>\n<li>Discussion on the remuneration report of the Members of the Management Board and the Supervisory Board.<\/li>\n<li>Adoption of a resolution on establishing an Incentive Programme in the Company and repealing Resolution No. 05\/02\/2021 of the Extraordinary General Meeting of the Company dated 9 February 2021, as amended by Resolution No. 19\/06\/2024 of the Ordinary General Meeting of the Company dated 26 June 2024.<\/li>\n<li>Adoption of a resolution on the issuance of registered subscription warrants of series A with the exclusion of pre-emptive rights of existing shareholders, conditional increase of the Company\u2019s share capital through the issuance of ordinary bearer shares of series H with the exclusion of pre-emptive rights of existing shareholders, repeal of Resolution No. 03\/02\/2021 of the Extraordinary General Meeting of the Company dated 9 February 2021 and Resolution No. 04\/02\/2021 of the Extraordinary General Meeting of the Company dated 9 February 2021, and the related amendment to the Company\u2019s Articles of Association.<\/li>\n<li>Closing of the General Meeting.<\/li>\n<\/ol>\n<p>The full text of the announcement convening the Ordinary General Meeting of the Company and the draft resolutions to be adopted at the Ordinary General Meeting of the Issuer, including the document containing a list of amendments to the Company\u2019s Articles of Association, are included in the attachments to this report.<\/p>\n<p>Furthermore, pursuant to Article 402(3) of the Commercial Companies Code, the full text of the announcement convening the Ordinary General Meeting, together with attachments including proxy voting forms, has been published on the website:<br \/>\n<a href=\"https:\/\/bioceltix.com\/ir\/walne-zgromadzenia\/\">https:\/\/bioceltix.com\/ir\/walne-zgromadzenia\/<\/a><\/p>\n<p>Detailed legal basis: Articles 402(1) and 402(2) of the Commercial Companies Code.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Attachments:<\/strong><\/p>\n<ol>\n<li>Announcement on convening the Ordinary General Meeting;<\/li>\n<\/ol>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/01.-BCX-Ogloszenie-o-zwolaniu-ZWZ.pdf\">BCX Og\u0142oszenie o zwo\u0142aniu ZWZ<\/a><\/p>\n<p>2. Draft resolutions together with justification;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/02.-BCX-Projekty-uchwal-ZWZ-wraz-z-uzasadnieniem.pdf\">BCX Projekty uchwa\u0142 ZWZ wraz z uzasadnieniem<\/a><\/p>\n<p>3. List of amendments to the Articles of Association;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/03.-BCX-Zestawienie-zmian-statutu.pdf\">BCX Zestawienie zmian statutu<\/a><\/p>\n<p>4. Draft consolidated text of the Articles of Association;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/04.-BCX-Projekt-tekstu-jednolitego.pdf\">BCX Projekt tekstu jednolitego<\/a><\/p>\n<p>5.\u00a0Opinion of the Management Board of the Company justifying the reasons for depriving shareholders of pre-emptive rights to subscription warrants and series H shares, and the method of determining the issue price of series H shares;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/05.-BCX-Opinia-Zarzadu_Podpisana.pdf\">BCX Opinia Zarz\u0105du_Podpisana<\/a><\/p>\n<p>6. Management Board\u2019s motion regarding coverage of the loss;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/06.-BCX-RN-wniosek-Zarzadu-dot.-straty-za-2025-rok-podpisany.pdf\">BCX RN wniosek Zarz\u0105du dot. straty za 2025 rok (podpisany)<\/a><\/p>\n<p>7. Supervisory Board\u2019s report on activities;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/07.-BCX-Sprawozdanie-Rady-Nadzorczej-z-dzialalnosci-za-rok-2025.pdf\">BCX Sprawozdanie Rady Nadzorczej z dzia\u0142alno\u015bci za rok 2025<\/a><\/p>\n<p>8. Remuneration report of the Members of the Management Board and the Supervisory Board;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/08.-Raport-bieglego-z-wykonania-uslugi-w-zakresie-oceny-sprawozdania-o-wynagrodzeniach.pdf\">Raport bieg\u0142ego z wykonania us\u0142ugi w zakresie oceny sprawozdania o wynagrodzeniach<\/a><\/p>\n<p>9. Report of the independent statutory auditor on the performance of the service regarding the assessment of the remuneration report;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/09.-Sprawozdanie-o-wynagrodzeniach.pdf\">Sprawozdanie o wynagrodzeniach<\/a><\/p>\n<p>10. Template of proxy form for shareholders;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/10.-BCX-Wzor-pelnomocnictwa.docx\">BCX Wz\u00f3r pe\u0142nomocnictwa<\/a><\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/10.-BCX-Wzor-pelnomocnictwa.pdf\">BCX Wz\u00f3r pe\u0142nomocnictwa<\/a><\/p>\n<p>11.\u00a0Voting form for proxy voting;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/11.-BCX-Fromularz-glosowania-przez-pelnomocnika.docx\">BCX Fromularz g\u0142osowania przez pe\u0142nomocnika<\/a><\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/11.-BCX-Fromularz-glosowania-przez-pelnomocnika.pdf\">BCX Fromularz g\u0142osowania przez pe\u0142nomocnika<\/a><\/p>\n<p>12. Information on the number of shares and votes;<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/12.-BCX-Informacja-o-liczbie-akcji.pdf\">BCX Informacja o liczbie akcji<\/a><\/p>\n<p>13. Information clause regarding the processing of personal data.<\/p>\n<p><a href=\"https:\/\/bioceltix.com\/wp-content\/uploads\/2026\/05\/13.-BCX-Klauzula-informacyjna-RODO.pdf\">BCX Klauzula informacyjna RODO<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Signatures of persons representing the Company:<\/strong><\/p>\n<p>\u0141ukasz Bzdzion \u2013 Prezes Zarz\u0105du<br \/>\nPawe\u0142 Wielgus \u2013 Cz\u0142onek Zarz\u0105du<\/p>\n<p>&nbsp;<\/p>\n<p>_MACHINE TRANSLATION_<\/p>\n","protected":false},"excerpt":{"rendered":"<p>_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cIssuer\u201d, the \u201cCompany\u201d), announces that the Ordinary General Meeting of the Issuer has been convened for 23 June 2026, to commence at 12:00 p.m. at the registered office of the Management Board of the Company, i.e. in Wroc\u0142aw (51-317), at [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[62],"tags":[],"class_list":["post-8649","post","type-post","status-publish","format-standard","hentry","category-general-meetings"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ordinary General Meeting convened for 23 June 2026 - Bioceltix<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ordinary General Meeting convened for 23 June 2026 - Bioceltix\" \/>\n<meta property=\"og:description\" content=\"_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cIssuer\u201d, the \u201cCompany\u201d), announces that the Ordinary General Meeting of the Issuer has been convened for 23 June 2026, to commence at 12:00 p.m. at the registered office of the Management Board of the Company, i.e. in Wroc\u0142aw (51-317), at [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Bioceltix\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T09:22:10+00:00\" \/>\n<meta name=\"author\" content=\"Bioceltix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bioceltix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/\"},\"author\":{\"name\":\"Bioceltix\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/person\\\/5ab725645ee04b83368bd6929813258a\"},\"headline\":\"Ordinary General Meeting convened for 23 June 2026\",\"datePublished\":\"2026-06-02T09:22:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/\"},\"wordCount\":868,\"publisher\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\"},\"articleSection\":[\"General meetings\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/\",\"name\":\"Ordinary General Meeting convened for 23 June 2026 - Bioceltix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#website\"},\"datePublished\":\"2026-06-02T09:22:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/ordinary-general-meeting-convened-for-23-june-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ordinary General Meeting convened for 23 June 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#website\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/\",\"name\":\"Bioceltix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bioceltix.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#organization\",\"name\":\"Bioceltix\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bioceltix.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-bioceltix.png\",\"contentUrl\":\"https:\\\/\\\/bioceltix.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-bioceltix.png\",\"width\":274,\"height\":73,\"caption\":\"Bioceltix\"},\"image\":{\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bioceltix.com\\\/#\\\/schema\\\/person\\\/5ab725645ee04b83368bd6929813258a\",\"name\":\"Bioceltix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g\",\"caption\":\"Bioceltix\"},\"url\":\"https:\\\/\\\/bioceltix.com\\\/en\\\/author\\\/bioceltix\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ordinary General Meeting convened for 23 June 2026 - Bioceltix","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ordinary General Meeting convened for 23 June 2026 - Bioceltix","og_description":"_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wroc\u0142aw (the \u201cIssuer\u201d, the \u201cCompany\u201d), announces that the Ordinary General Meeting of the Issuer has been convened for 23 June 2026, to commence at 12:00 p.m. at the registered office of the Management Board of the Company, i.e. in Wroc\u0142aw (51-317), at [&hellip;]","og_url":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/","og_site_name":"Bioceltix","article_published_time":"2026-06-02T09:22:10+00:00","author":"Bioceltix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bioceltix","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/#article","isPartOf":{"@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/"},"author":{"name":"Bioceltix","@id":"https:\/\/bioceltix.com\/#\/schema\/person\/5ab725645ee04b83368bd6929813258a"},"headline":"Ordinary General Meeting convened for 23 June 2026","datePublished":"2026-06-02T09:22:10+00:00","mainEntityOfPage":{"@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/"},"wordCount":868,"publisher":{"@id":"https:\/\/bioceltix.com\/#organization"},"articleSection":["General meetings"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/","url":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/","name":"Ordinary General Meeting convened for 23 June 2026 - Bioceltix","isPartOf":{"@id":"https:\/\/bioceltix.com\/#website"},"datePublished":"2026-06-02T09:22:10+00:00","breadcrumb":{"@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bioceltix.com\/en\/ordinary-general-meeting-convened-for-23-june-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/bioceltix.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ordinary General Meeting convened for 23 June 2026"}]},{"@type":"WebSite","@id":"https:\/\/bioceltix.com\/#website","url":"https:\/\/bioceltix.com\/","name":"Bioceltix","description":"","publisher":{"@id":"https:\/\/bioceltix.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bioceltix.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bioceltix.com\/#organization","name":"Bioceltix","url":"https:\/\/bioceltix.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bioceltix.com\/#\/schema\/logo\/image\/","url":"https:\/\/bioceltix.com\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","contentUrl":"https:\/\/bioceltix.com\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","width":274,"height":73,"caption":"Bioceltix"},"image":{"@id":"https:\/\/bioceltix.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/bioceltix.com\/#\/schema\/person\/5ab725645ee04b83368bd6929813258a","name":"Bioceltix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b441a3f41947338957e10d677306f0621fd7537fb2275d250f6e77a75183d336?s=96&d=mm&r=g","caption":"Bioceltix"},"url":"https:\/\/bioceltix.com\/en\/author\/bioceltix\/"}]}},"_links":{"self":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/comments?post=8649"}],"version-history":[{"count":1,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8649\/revisions"}],"predecessor-version":[{"id":8650,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/posts\/8649\/revisions\/8650"}],"wp:attachment":[{"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/media?parent=8649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/categories?post=8649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioceltix.com\/en\/wp-json\/wp\/v2\/tags?post=8649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}